InvestorsHub Logo
Followers 10
Posts 343
Boards Moderated 0
Alias Born 10/28/2011

Re: None

Friday, 08/30/2013 3:56:37 PM

Friday, August 30, 2013 3:56:37 PM

Post# of 1302
1. Q2 revenue hiccup?
2. Near end of Q1 U.S. FDA requested/received full data set before "giving-guidance" for marketing in the U.S.
3. Currently: no guidance received yet from the FDA review of the DATA sets, which are now 6x Aura vs MD(top notch board trained dermatologists) scans with double blind lesional biopsies for confirmation? awaiting clear confirmation of this.
4. FDA under constraints of a "concrete bowel obstruction" aka "do nothing" Congress......
5. time will tell if VRSEF managers wasted all the effort getting that test data to the FDA.
6. today there is blood on the dance floor and large volume offers stand on the U.S. OTCQX at the 45k shares for .28 USD/share at approx 9 mins to close.
7. today VRSEF stock looks to close somewhere south at the 21% range in the RED on day/day trading. STOCK DOWN TODAY 22% at ten mins to close.
8. exciting times in this sector where the time and money crunch showed by management for the Q2 stats look to make long holders anxious......
9. i think the risk/return has moved adversely and hopefully this will prove to have been a hiccup and short lived shake to our little tree here in Verisante.
10. confidence level = very high that the research needed presenting to the FDA. Confidence level = very high that the majority in congress are douche-bags